Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8.3

businesswire.com

Form 8.3 LONDON--( BUSINESS WIRE)--

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

(a) Full name of discloser

Millennium International Management LP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Forward Industries Inc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

10 th June 2026

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes, Brera Holdings plc

2. INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security

(Note 3)

$0.01 ordinary shares (US3499321038)

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

1,228,229

1.665%

129,309

0.175%

(2) Cash-settled derivatives

-

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

-

-

-

-

Total

1,228,229

1.665%

129,309

0.175%

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant

security

Purchase/sale

Number of

securities

Price per unit

(Note 5)

(USD)

US3499321038

Purchase

122

3.85

US3499321038

Purchase

45

3.86

US3499321038

Purchase

24

3.88

US3499321038

Sale

173

3.85

US3499321038

Sale

32

3.86

US3499321038

Sale

41

3.87

US3499321038

Sale

41

3.92

US3499321038

Sale

1

3.93

US3499321038

Sale

19

3.94

US3499321038

Purchase

9254

3.85

US3499321038

Purchase

209

3.86

US3499321038

Purchase

7212

3.87

US3499321038

Purchase

3747

3.88

US3499321038

Purchase

6014

3.89

US3499321038

Purchase

8161

3.9

US3499321038

Purchase

3246

3.91

US3499321038

Purchase

3761

3.92

US3499321038

Purchase

10051

3.93

US3499321038

Purchase

759

3.94

US3499321038

Purchase

665

3.95

US3499321038

Purchase

149

3.96

US3499321038

Purchase

3641

3.97

US3499321038

Purchase

3443

3.98

US3499321038

Purchase

11055

3.99

US3499321038

Purchase

6379

4

US3499321038

Purchase

14025

4.01

US3499321038

Purchase

7203

4.02

US3499321038

Purchase

2819

4.03

US3499321038

Purchase

4932

4.04

US3499321038

Purchase

3075

4.05

US3499321038

Purchase

1662

4.06

US3499321038

Purchase

1954

4.07

US3499321038

Purchase

3788

4.08

US3499321038

Purchase

1682

4.09

US3499321038

Purchase

597

4.1

US3499321038

Purchase

251

4.11

US3499321038

Purchase

74

4.12

US3499321038

Purchase

45

4.13

US3499321038

Purchase

20

4.14

US3499321038

Purchase

23

4.16

US3499321038

Sale

9459

3.85

US3499321038

Sale

2454

3.92

US3499321038

Sale

1154

4.05

US3499321038

Sale

777

3.86

US3499321038

Sale

5833

3.87

US3499321038

Sale

700

3.88

US3499321038

Sale

856

3.89

US3499321038

Sale

100

3.91

US3499321038

Sale

1107

3.92

US3499321038

Sale

1389

3.93

US3499321038

Sale

4861

3.94

US3499321038

Sale

206

3.96

US3499321038

Sale

100

4.04

US3499321038

Sale

1180

4.05

US3499321038

Sale

602

4.06

US3499321038

Sale

1850

4.07

US3499321038

Sale

1936

4.08

US3499321038

Sale

481

4.1

US3499321038

Sale

10

4.11

US3499321038

Sale

2256

4.12

US3499321038

Purchase

111

3.84

US3499321038

Purchase

5572

3.85

US3499321038

Purchase

200

3.86

US3499321038

Purchase

526

3.88

US3499321038

Purchase

1219

3.89

US3499321038

Purchase

1203

3.91

US3499321038

Purchase

663

3.92

US3499321038

Purchase

1251

3.93

US3499321038

Purchase

1017

4.04

US3499321038

Sale

1203

3.85

US3499321038

Sale

53

3.88

US3499321038

Sale

38

3.89

US3499321038

Sale

17

3.9

US3499321038

Sale

1203

3.91

US3499321038

Sale

690

3.92

US3499321038

Sale

1435

3.93

US3499321038

Sale

191

3.94

US3499321038

Sale

43

3.95

US3499321038

Sale

79

3.96

US3499321038

Sale

77

3.97

US3499321038

Sale

31

4.02

US3499321038

Sale

30

4.03

US3499321038

Sale

1017

4.04

US3499321038

Sale

61

4.05

US3499321038

Sale

140

4.06

US3499321038

Sale

34

4.07

US3499321038

Sale

2587

4.08

US3499321038

Sale

117

4.09

US3499321038

Sale

35

4.1

US3499321038

Sale

52

4.11

US3499321038

Sale

24

4.12

US3499321038

Sale

45

4.13

US3499321038

Sale

23

4.16

US3499321038

Purchase

160

3.84

US3499321038

Purchase

15166

3.85

US3499321038

Purchase

220

3.86

US3499321038

Purchase

144

3.87

US3499321038

Purchase

4009

3.88

US3499321038

Purchase

4633

3.89

US3499321038

Purchase

24

3.9

US3499321038

Purchase

681

3.91

US3499321038

Purchase

901

3.92

US3499321038

Purchase

40

3.93

US3499321038

Purchase

81

3.94

US3499321038

Purchase

460

3.95

US3499321038

Purchase

968

3.96

US3499321038

Purchase

2808

3.99

US3499321038

Purchase

717

4.04

US3499321038

Purchase

249

4.05

US3499321038

Purchase

70

4.06

US3499321038

Purchase

103

4.1

US3499321038

Purchase

92

4.12

US3499321038

Sale

160

3.84

US3499321038

Sale

13789

3.85

US3499321038

Sale

168

3.86

US3499321038

Sale

144

3.87

US3499321038

Sale

2907

3.88

US3499321038

Sale

1250

3.89

US3499321038

Sale

24

3.9

US3499321038

Sale

681

3.91

US3499321038

Sale

962

3.92

US3499321038

Sale

6412

3.93

US3499321038

Sale

74

3.94

US3499321038

Sale

474

3.95

US3499321038

Sale

200

3.97

US3499321038

Sale

29

3.98

US3499321038

Sale

719

3.99

US3499321038

Sale

200

4

US3499321038

Sale

1

4.02

Ap29

(b) Cash-settled derivative transactions

Class of

relevant

security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of

reference

securities

(Note 6)

Price

per unit

(Note 5)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of

relevant

security

Product

description e.g. call

option

Writing, purchasing, selling, varying

etc.

Number

of

securities

to which

option

relates

(Note 6)

Exercise

price per

unit

Type

e.g.

American,

European

etc.

Expiry

date

Option

money

paid/

received per unit

(ii) Exercise

Class of

relevant

security

Product

description

e.g. call

option

Exercising/

exercised

against

Number of

securities

Exercise

price per

unit

(Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 3)

Class of

relevant

security

Nature of dealing

e.g. subscription,

conversion, exercise

Details

Price per unit (if

applicable)

(Note 5)

Ap30

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

(c) Attachments

Is a Supplemental Form 8 attached?

NO

Date of disclosure

11 th June 2026

Contact name

Stephen Glasper

Telephone number

+44 203 398 2166

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap31

NOTES ON FORM 8.3

1. See the definition of “connected fund manager” in Rule 2.2 of Part A of the Rules.

2. See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

3. See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules.

4. See the definition of “dealing” in Rule 2.1 of Part A of the Rules.

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

6. See Rule 2.5(d) of Part A of the Rules.

7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.